Company Long-Term Loans and Borrowings: Cara Therapeutics, Inc (CARA)
The price evolution of Cara Therapeutics, Inc. (CARA) demonstrates a current level of 0.00. The business specializes in the therapy of nephrogenic pruritus, generating moderate revenue from licenses and sales. However, trial failures have triggered an acute funding shortage, forcing management to aggressively cut costs. In the long term, margin sustainability is supported by the deep integration of drugs into dialysis center protocols, which creates inertial demand.
Summary analytical data breakdowns for Cara Therapeutics, Inc (CARA)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Total Debt to Capital Cara Therapeutics, Inc.|CARA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Cara Therapeutics Inc|CARA - Company Aggregate Debts|Debts to Book Capitalization Cara Therapeutics|CARA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Cara Therapeutics|Intermediate Liquidity Ratio caratherapeutics.com
- earnings and market multiples details:
Summary company analytics:CARA (caratherapeutics.com)
Liability dynamics depend on the financing strategy and operational efficiency of Cara Therapeutics, Inc. (CARA). This metric reflects the aggregate of loans with maturities exceeding one year, reacting to changes in interest rates. High pricing power in molecule licensing and inelastic demand for Corsuvia allow the company to service such loans. By analyzing the firm's long-term debt structure, an investor assesses the balance between scaling and financial stability.
Competitor analysis for Cara Therapeutics, Inc.
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities vikingtherapeutics.com (VKTX)|Company Long-Term Debts SUPN|Company Long-Term Debts Catalyst Pharma (CPRX)|Company Long-Term Debt Denali Therapeutics Inc DNLI|Company Long-Term Loans and Borrowings HRMY|Biohaven Ltd. - Company Long-Term Debts|AMLX - Company Long-Term Debts|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Liabilities|Praxis Precision Medicines Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities AVXL|CBLL (CeriBell EEG) - Amount of Long-Term Liabilities|Company Long-Term Debts PRTA|ALEC (alector.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ANNX (Annexon)|Omeros Corp (OMER) - Long-Term Debt|NGNE - Company Long-Term Debt|Company Long-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Long-Term Debts|neumoratx.com (NMRA) - Company Long-Term Debts|Company Long-Term Debt Scilex|Tevogen Bio Holdings Inc. - Long-Term Liabilities|Company Long-Term Debts ACOG|CGTX - Long-Term Debt|Inhibikase Therapeutics - Company Long-Term Liabilities|Company Long-Term Debts cassavasciences.com SAVA|ASRT: Company Long-Term Liabilities|Coya Therapeutics, Inc. - Amount of Long-Term Liabilities|VTGN: Company Long-Term Debts|OVID - Long-Term Debt Volume|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities cervomed.com (CRVO)|Company Long-Term Debt Alterity Therapeutics (ATHE)|Long-Term Debt Volume clene.com|PepGen - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings JUNS|Relmada Therapeutics - Company Long-Term Debts|Long-Term Debt Volume annovisbio.com ANVS|gracetx.com (GRCE) - Company Long-Term Debt|Company Long-Term Indebtedness AIFF|KLTO (ANEW Medical) - Company Long-Term Debts|Company Long-Term Liabilities NeuroSense Therapeutics, Ltd. (NRSN)|Company Long-Term Liabilities RVPH (Reviva Pharmaceuticals)|Long-Term Debt Volume metaviatx.com|Company Long-Term Debts NRXS (NeurAxis)|HSDT - Company Long-Term Liabilities|Passage Bio Corp - Company Long-Term Debts|NEUP - Company Long-Term Debts|Minerva Neurosciences (NERV) - Company Long-Term Debt|athira.com - Company Long-Term Loans and Borrowings|ADXN (Addex Therapeutics Ltd) - Company Long-Term Debts|Company Long-Term Debts Alzamend|Company Long-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Long-Term Indebtedness|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Long-Term Debt|ATXI: Company Long-Term Liabilities|BCLI - Company Long-Term Debts|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Eliem Therapeutics Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Debt Intra-Cellular Therapies Inc.|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Debts MRNS|Company Long-Term Liabilities NKGen Biotech Inc NKGN|Company Long-Term Debts NRBO (NeuroBo)|Company Long-Term Debts Sage Therapeutics Inc SAGE|SNPX - Company Long-Term Debt|Company Long-Term Loans and Borrowings TRVN (trevena.com)|VIGL: Company Long-Term Debts|Anew Medical Inc. (WENA) - Company Long-Term Debts|Company Long-Term Liabilities CERE